Today’s Second Circuit Court of Appeals decision supporting the Food and Drug Administration’s (FDA) decision to pursue a collaborative stakeholder process to implement significant changes to antibiotic use rather than a regulatory action is a welcome development. The court joins the Center for Disease Control and the President’s Council of Advisors on Science and Technology [...]
AHI members in the biologics industry continue to invest millions of dollars in the development of effective vaccines to advance the control and eradication of zoonotic disease in animals. Working closely with the USDA Center for Veterinary Biologics (CVB) these vaccines are licensed and made available to the animal health industry.
Learn how AHI member companies are advancing research in animal vaccines.